Integra Lifesciences I v. Merck Kgaa.

CourtCourt of Appeals for the Federal Circuit
DecidedAugust 17, 2005
Docket2002-1052
StatusPublished

This text of Integra Lifesciences I v. Merck Kgaa. (Integra Lifesciences I v. Merck Kgaa.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Integra Lifesciences I v. Merck Kgaa., (Fed. Cir. 2005).

Opinion

Error: Bad annotation destination United States Court of Appeals for the Federal Circuit

02-1052, -1065

INTEGRA LIFESCIENCES I, LTD. and THE BURNHAM INSTITUTE,

Plaintiffs-Cross Appellants, and

TELIOS PHARMACEUTICALS, INC.,

Plaintiff-Appellee,

v.

MERCK KGaA,

Defendant-Appellant, and

THE SCRIPPS RESEARCH INSTITUTE and DR. DAVID A. CHERESH,

Defendants.

Donald R. Dunner, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., of Washington, DC, argued for defendant-appellant Merck KGaA. With him on the brief were Thomas H. Jenkins, David A. Manspeizer, and Rachel H. Townsend. Of counsel on the brief were M. Patricia Thayer, Heller Ehrman White & McAuliffe, LLP, of San Francisco, California; and William C. Rooklidge, Howrey Simon Arnold & White, LLP, of Irvine, California. Of counsel was Esther H. Lim, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., of Washington, DC.

Mauricio A. Flores, Campbell & Flores LLP, of San Diego, California, argued for plaintiffs-cross appellants Integra LifeSciences I, Ltd. and The Burnham Institute. With him on the brief was David M. Beckwith. Of counsel on the brief were Raphael V. Lupo, Mark G. Davis, and Natalia V. Blinkova, McDermott, Will & Emery, of Washington, DC. Of counsel was Donna M. Tanguay.

Appealed from: United States District Court for the Southern District of California

Senior Judge James M. Fitzgerald, District of Alaska United States Court of Appeals for the Federal Circuit

Plaintiffs-Cross Appellants,

and

Defendant-Appellant,

Before NEWMAN, RADER, and PROST, Circuit Judges.

ORDER

The court has received a certified copy of the judgment from the Clerk of the

Supreme Court of the United States in Merck KGaA v. Integra Lifesciences I, Ltd., No. 03-

1237. The Supreme Court vacated this court's judgment, which was reported at 331 F.3d

860 (Fed. Cir. 2003), and remanded for proceedings consistent with the Court's opinion. Upon consideration thereof,

IT IS ORDERED THAT:

(1) The mandate is hereby recalled and the appeal is reinstated.

(2) The case is returned to the original merits panel.

(3) New briefs shall be filed, with particular attention paid to the Supreme Court

decision.

(4) The appellants' principal brief shall be due within 60 days of the date of filing

of this order. The dates for filing the remaining briefs shall be in accordance with Fed. Cir.

R. 31(a). An original and 22 copies of all briefs shall be filed, and two copies shall be

served on opposing counsel. The court sua sponte allows amicus briefs.

FOR THE COURT

_Aug 17 2005__ _s/Jan Horbaly_____ Date Jan Horbaly Clerk

cc: Donald R. Dunner, Esq. Mauricio A. Flores, Esq.

02-1052, -1065 2

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
Integra Lifesciences I v. Merck Kgaa., Counsel Stack Legal Research, https://law.counselstack.com/opinion/integra-lifesciences-i-v-merck-kgaa-cafc-2005.